Editas Medicine (EDIT) Current Deferred Revenue (2016 - 2025)
Editas Medicine (EDIT) reported Current Deferred Revenue of $2 million for Q1 2025, down 86.4% from $14.68 million a year earlier and down 67.9% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Current Deferred Revenue (2016 - 2025) Analysis & Trends
At the end of FY2024, Editas Medicine posted Current Deferred Revenue of $6.22 million, down 24.3% from FY2023.
- Current Deferred Revenue has a five-year compound annual growth rate of -23.4% (FY2019 to FY2024).
- By year, Current Deferred Revenue came in at $8.22 million in FY2023 (unchanged), $8.22 million in FY2022 (-27.5%), $11.33 million in FY2021 (-45.9%) and $20.94 million in FY2020 (-10.9%).
- The Q1 2025 figure ranks as the lowest quarterly Current Deferred Revenue since Q4 2016.
- Year over year, Current Deferred Revenue gained in four of the last seven quarters, with growth averaging 31.4%.
- The high point for year-over-year Current Deferred Revenue in five years was Q3 2023 (growth of 94.8%); the low point was Q1 2025 (a decline of 86.4%).
- Per Business Quant data, the three quarters before Q1 2025 came in at $6.22 million (Q4 2024), $14.68 million (Q3 2024) and $14.68 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Editas Medicine | 222.97 Mn | -488.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 6.22 Mn |
| Sep 30, 2024 | 14.68 Mn |
| Jun 30, 2024 | 14.68 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | 8.22 Mn |
| Sep 30, 2023 | 8.22 Mn |
| Jun 30, 2023 | 8.22 Mn |
| Mar 31, 2023 | 8.22 Mn |
| Dec 31, 2022 | 8.22 Mn |
| Sep 30, 2022 | 4.22 Mn |
| Mar 31, 2022 | 5.82 Mn |
| Dec 31, 2021 | 11.33 Mn |
| Sep 30, 2021 | 22.67 Mn |
| Jun 30, 2021 | 34.00 Mn |
| Mar 31, 2021 | 32.70 Mn |
| Dec 31, 2020 | 20.94 Mn |
| Sep 30, 2020 | 19.87 Mn |
| Jun 30, 2020 | 40.94 Mn |
| Mar 31, 2020 | 40.64 Mn |
API Access
Editas Medicine Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();